Targeted Radiation Therapy for Low to Intermediate Risk Prostate Cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new radiation treatment approach that uses MRI imaging to target specific tumor areas within the prostate while reducing radiation to healthy tissue. It may help patients with early-stage prostate cancer get effective treatment with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with low to intermediate risk prostate cancer (not high-grade or advanced)
- Your PSA level is 20 ng/mL or lower
- You have had an MRI-guided biopsy showing visible lesions in your prostate
- You have good overall health and can reasonably expect to live more than 5 years
- You can safely undergo MRI scans without metallic implants or other barriers
- Your urinary function is good (low symptom score on a standardized questionnaire)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special type of radiation therapy (SBRT) that delivers a higher dose directly to the main tumor in your prostate, guided by a PSMA PET scan. It aims to improve cancer control while limiting side effects.
This trial tests a newer, more precise radiation treatment that gives a higher dose to the main tumor while keeping radiation to the rest of the prostate the same. It is for men with intermediate- or high-risk prostate cancer who haven't had prior prostate radiation or removal.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This trial studies whether adding a stronger “boost” dose of targeted radiation (SBRT) can better control higher-risk prostate cancer. It may help by increasing radiation coverage to the prostate while trying to limit treatment to surrounding areas.
This study tests whether adding a stronger, focused radiation “boost” to a visible prostate spot—using real-time MRI guidance—can improve treatment for locally advanced prostate cancer. It may help better control the tumor while still delivering standard radiation to the rest of the prostate area.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.